M. Colombo

Hepatology · 2001–2021

A researcher in the Science corpus: 8 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom M. Colombo trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Jordi Bruix1 , 2 (in Hepatology)
  2. J. Llovet (in Hepatology)

Who trusts M. Colombo

  1. Jordi Bruix1 , 2 (in Hepatology)

Papers from M. Colombo's perspective

Ordered by how strongly the researchers M. Colombo trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Novel advancements in the management of hepatocellular carcinoma in 2008. (Journal of Hepatology)
  2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (The Lancet Oncology)
  3. Molecular Targeted Therapies in Hepatocellular Carcinoma (Hepatology)
  4. The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients (Hepatology)
  5. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. (Journal of Hepatology)
  6. Noninvasive assessment of liver fibrosis (Hepatology)
  7. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. (Gastroenterology)
  8. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? (Hepatology)
  9. Randomized controlled trial of screening for hepatocellular carcinoma (Journal of Cancer Research and Clinical Oncology)
  10. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival (Hepatology)

Their papers